Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
220.69
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Charles River Laboratories Intl
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
ROSEN, A LEADING LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
May 29, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Exposures
Financial
Legal
Securities Class Action Reminder (NYSE: CRL): Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
May 28, 2023
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
May 27, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Exposures
Financial
Legal
Charles River: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Will Chart Analysts Notice Bad Omen on Charles River's Chart
April 13, 2023
Via
Benzinga
Analyst Ratings for Charles River
March 28, 2023
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm
May 24, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
May 24, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors
May 23, 2023
From
Kirby McInerney LLP
Via
Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
May 23, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors
May 23, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
May 23, 2023
From
The Schall Law Firm
Via
Business Wire
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc.
May 23, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Charles River Laboratories International, Inc. (CRL)
May 23, 2023
From
Robbins LLP
Via
Business Wire
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL
May 22, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
May 22, 2023
From
The Schall Law Firm
Via
Business Wire
CRL EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CRL
May 22, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors
May 22, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. and Encourages Investors to Contact the Firm
May 21, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
CRL CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.
May 21, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
CRL CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.
May 19, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
3 DNA Stocks to Buy for the Synthetic Biology Revolution
May 14, 2023
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.
Via
InvestorPlace
Charles River Laboratories Announces First-Quarter 2023 Results
May 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
May 01, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
3 Healthcare Stocks With Huge Growth Potential
April 24, 2023
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead.
Via
InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Fox, Charles River, Provident, and Sarepta and Encourages Investors to Contact the Firm
April 17, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
April 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
April 10, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, FTX, RH, and Charles River and Encourages Investors to Contact the Firm
March 22, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
March 17, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Law Enforcement
Supply Chain
Exposures
Legal
Supply Chain
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.